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Abstract
In the present study, the adapted multiple point stimulation (AMPS) method was first applied to median innervated thenar muscles in 22
amyotrophic lateral sclerosis (ALS) patients who did not received any treatment. In all patients, a motor unit number estimate (MUNE) and
an average surface-recorded motor unit action potential (S-MUAP) size have been derived even if the denervation was severe; and the
results were reproducible. The thenar MUNE was less than the normal lower limit for age in 17 patients, and the mean MUNE (67.1 ± 90.6)
was significantly different from that estimated in control subjects (263.3 ± 116.8). The mean S-MUAP size in the 22 ALS patients was
352.9 ± 328.4 mV⋅ms versus 94.1 ± 30.3 mV⋅ms in healthy volunteers. A control AMPS was achieved in 8 patients after 2 and 6 months of a
glutamate-release antagonist (riluzole) treatment. The mean loss of motor units, based on control thenar MUNEs realized after 6 months of
treatment, was 53%. In conclusion, we propose AMPS as a manageable, reproducible and non-invasive procedure which permits one to
quantify peripheral denervation and to appreciate the effectiveness of collateral reinnervation in ALS patients.  1998 Elsevier Science
Ireland Ltd.
Keywords: Surface-recorded motor unit action potential (S-MUAP); Motor unit number estimate (MUNE); Amyotrophic lateral sclerosis
(ALS); Adapted multiple point stimulation method (AMPS)
1. Introduction
Electromyography (EMG) is useful in the diagnosis of
amyotrophic lateral sclerosis (ALS) (Lambert, 1969; Corn-
blath et al., 1992) but provides little information for ade-
quate assessment of amyotrophy and its course. Other
electrophysiological techniques are, however, available to
study quantitatively pathophysiological changes in ALS
muscles such as motor unit loss and the size increase of
the remaining motor units (Brown and Jaatoul, 1974;
Swash and Schwartz, 1982; Sta˚lberg and Sanders, 1984;
Dantes and McComas, 1991; Bromberg, 1993). All these
methods should be of clinical interest in monitoring the
patients’ clinical course and in assessing the efficacy of
various treatments. Unfortunately, most of these techniques
are too sophisticated for routine clinical use or are not com-
pletely free of methodological biases (Wang and Delwaide,
1995a). The adapted multiple point stimulation (AMPS)
method is, in control subjects, an easier procedure devoid
of methodological bias (Wang and Delwaide, 1995a,b); it
has promise for ALS patients.
In the present study, we used first AMPS in 22 ALS
patients to quantify denervation (motor unit number esti-
mate: MUNE) at a particular moment in the evolution of
this illness (cross-sectional evaluation) and to estimate the
size of the remaining motor units (average surface-recorded
motor unit action potential size: average S-MUAP size).
After this first step, in 8 ALS patients, the thenar motor
unit number and average S-MUAP size were estimated
again (longitudinal evaluation), by using AMPS, after 2
and 6 months of treatment by a glutamate-release antagonist
(riluzole).
2. Methods and materials
2.1. Subjects
Data were collected from 22 patients with ALS (12 men
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and 10 women), after having obtained their informed con-
sent; age ranged from 36 to 77 years (mean 62 ± 13) (Table
1). These patients fulfilled clinical and electrophysiological
criteria for definite ALS (Brooks, 1994). None of the
patients suffered from any additional pathology which
would give rise to neuropathic or myopathic changes. At
the start of the study none received drug therapy; but
later, 8 patients received riluzole and a thenar motor unit
number and average S-MUAP size estimation were realized
after 2 and 6 months of treatment.
Table 1 summarizes clinical and electrophysiologi-
cal observations in the 22 ALS patients. Four patients
(patients 4, 11, 13 and 15) were bed-ridden at the time of
the study and died a few months later (terminal clinical
stage). When AMPS was applied, 6 patients (patients 1,
5, 12, 19, 21 and 22) had neither clinical amyotrophy nor
electrophysiological evidence of thenar muscle involve-
ment.
Results in patients were compared with those published
earlier from 70 healthy control subjects of both sexes
and different ages ranging from 19 to 93 years (mean
50 ± 20) (Wang and Delwaide, 1995a,b). As the 3 studied
variables (MUNE, average S-MUAP size, maximum M-
potential size) depend on age, each patient result was
assessed by comparing it with the normal limits in terms
of age (Fig. 1).
2.2. AMPS technique
The number and relative size of thenar motor units were
estimated by the AMPS technique. This method, with its
advantages and its reliability, has been presented in detail
in an earlier paper (Wang and Delwaide, 1995a). With
AMPS, the motor unit size was estimated by collecting
and averaging 10 well identified S-MUAPs after stimulation
at distinct points along the course of the median nerve
between the wrist and elbow. At each stimulation site,
only two or 3 S-MUAPs were evoked by incremental sti-
mulation. To avoid alternation and ensure that any incre-
ment of the motor response corresponded to the activation
of one single motor unit, S-MUAPs had to be evoked in an
all-or-nothing, orderly and reproducible manner, with dis-
tinct thresholds and without any fractionation of the com-
pound motor responses to successive identical stimuli. By
dividing the maximum M-potential size by the average S-
MUAP size, a MUNE was obtained. Negative peak area
measurements (from the onset of the first negative peak
until the first crossing with the baseline) were selected to
evaluate motor unit sizes and maximum M-potential sizes.
Motor unit potentials that were predominantly or entirely
positive in configuration were rejected from the analysis as
these potentials were not supposed to be elicited by motor
units with end-plates close to the stigmatic electrode. Small
Table 1
Summary of observations on patients with ALS
Patient Sex Age
(years)
TMI MUNE Average S-MUAP size (mV⋅ms) Maximum M-poten-
tial size (mV⋅ms)
I (LNL) II III I (UNL) II III I (LNL)
1 M 39 0 360 (144)a 87 (154)a 31.3 (11.3)a
2 F 51 + 22 (119) 278 (162) 6.1 (8.7)
3 M 72 + 66 (86) 181 (180) 11.9 (4.1)a
4b M 64 + 13 (96) 194 (173) 2.5 (5.9)
5 F 74 0 185 (83)a 112 (182)a 20.7 (3.7)a
6 M 70 + 17 (88) 1250 (178) 21.3 (4.6)a
7 M 76 + 50 (80) 169 (184)a 8.5 (3.5)a
8 F 70 + 41 (88) 244 (178) 10 (4.6)a
9 M 47 + 6 (127) 1167 (160) 7 (9.5)
10 F 70 + 17 (88) 353 (178) 6 (4.6)a
11b M 54 + 5 (114) 252 (165) 1.3 (8)
12 M 70 0 81 (88) 307 (178) 24.9 (4.6)a
13b F 77 + 4 (79) 221 (185) 0.9 (3.1)
14 M 36 + 20 (150) 16 9 464 (152) 409 794 9.3 (11.9)
15b F 48 + 3 (125) 3 1 228 (160) 129 238 0.7 (9.3)
16 F 72 + 26 (86) 10 10 293 (180) 307 157 7.6 (4.1)a
17 F 58 + 6 (107) 3 3 923 (168) 982 944 5.5 (7.2)
18 F 65 + 35 (95) 17 9 339 (174) 404 540 11.9 (5.6)a
19 M 73 0 215 (84)a 116 (181)a 24.9 (3.9)a
20 M 58 + 13 (107) 6 3 363 (168) 888 2265 4.7 (7.2)
21 M 46 0 149 (129)a 104 81 150 (159)a 212 284 22.4 (9.7)a
22 F 68 0 143 (91)a 114a 70 73 (177)a 184 238 10.4 (5)a
I, II, III = respectively before and after 2 and 6 months of riluzole therapy. MUNE, motor unit number estimate; S-MUAP, surface-recorded motor unit action
potential; TMI, thenar muscle involvement (clinical amyotrophy and classical electromyographic signs of motor denervation).
aValue within lower and upper normal limits (LNL and UNL) related to age.
bALS patients bed-ridden at the time of the study who died a few months later (terminal clinical stage).
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motor unit potentials with an initial positive phase, likely
recorded from the lumbrical muscles, were also rejected.
All studies were performed on a Nicolet Viking I EMG
machine (Nicolet Instrument Corp.). S-MUAPs were
evoked by stimuli of 0.05 ms duration, delivered by surface
electrodes (Medelec model LBS 53051; inter-electrode dis-
tance: 2.5 cm) at 1 Hz with gradually increased intensity
from a subthreshold value with incremental steps of 0.1–0.5
mA. Motor responses were recorded (band-pass: 20 Hz–5
KHz) with surface electrodes (silver foils, 6 cm long and 0.8
cm wide). The stigmatic electrode was placed as close as
possible to the thenar muscle end-plates. The reference elec-
trode was attached over the proximal phalanx of the thumb.
The ground electrode was fixed over the dorsum of the
wrist. The hand temperature was maintained above 30°C.
2.3. Conventional EMG and nerve conduction study
All patients underwent motor and sensory nerve conduc-
tion measurements in upper and lower limbs bilaterally and
concentric needle recordings from at least 3 limbs including
the thenar muscles where MUNEs were obtained. In the
present study, thenar muscle involvement was established
if fibrillation potentials and/or large amplitude and duration
motor unit action potentials were recorded.
2.4. Statistical analysis
Mean values have been expressed with their standard
deviations. The significance of differences between means
was determined by Student’s t tests for independent samples
or paired Student’s t tests. When the variable under study
evolved exponentially, a logarithmic transform of the values
preceded Student’s t tests. Correlations between results, and
results and age, have been calculated with regression ana-
lyses. Reproducibility of AMPS in ALS patients was esti-
mated by the coefficient of variation between data collected
on two successive trials.
3. Results
3.1. AMPS in ALS patients
Application of AMPS in ALS patients requires some
comments. Theoretically, in case of pronounced motor
denervation, it might be more difficult to find enough points
from which to evoke distinct S-MUAPs than in normal sub-
jects. In practice, however, and in particular in this study, it
was easier to derive MUNEs in ALS patients than in healthy
volunteers. Indeed, as previously reported (Brown and Mil-
ner-Brown, 1976), there is less overlap of motor unit thresh-
olds when denervation is severe and, therefore, alternation
is less noticeable. When the motor unit number is very low,
it may sometimes be better to evoke more than 3 S-MUAPs
without alternation from the same point using incremental
stimulation. Therefore, two or 3 different stimulation points
along the course of the median nerve are enough to derive
an MUNE. If there are less than 10 motor units remaining in
some patients, the best way to derive a MUNE is sometimes
to find one stimulation point from which it is possible to
activate the few remaining motor units without alternation.
In these particular cases (5 patients in the present study),
AMPS is very similar to the initial estimation technique
described by McComas et al. (1971a).
3.2. Test/retest reliability
In 10 ALS patients, the thenar MUNE and average S-
Fig. 1. Motor unit number estimate (MUNE) (A), average surface-recorded
motor unit action potential (S-MUAP) size (B), and maximum M-potential
size (C) in terms of age in normal subjects (small circles) and amyotrophic
lateral sclerosis (ALS) patients (dots; large circles = ALS patients at the
terminal stage). In controls, prediction limits with a P-level of 0.05 give
the lower and upper normal limits. (A) Three patients had thenar MUNE
within normal limits, all the others had MUNE below the lower normal
limit including even patient 12 who did not have clinical and classical
electrophysiological evidence of thenar muscle involvement. (B) Four
patients had thenar average S-MUAP sizes within normal limits while
the others had motor unit sizes above the upper normal limit. In patients
with ALS in a terminal clinical stage, average S-MUAP size was increased
only moderately. (C) Eleven patients had maximum M-potential size
within normal limits. Only 9 patients, in particular those with ALS in a
terminal clinical stage, had maximum M-potential sizes less than the lower
normal limit.
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MUAP size were evaluated twice in the same session using
AMPS by the same examiner after removal and replacement
of surface recording electrodes for second trial. Results of
MUNEs from the two trials were significantly correlated
(r = 0.97, P ! 0.001) and the calculated coefficient of var-
iation was 4% (Fig. 2A). Results of average S-MUAP sizes
from the two trials were also correlated (r = 0.92,
P ! 0.001) and the calculated coefficient of variation was
4% (Fig. 2B).
3.3. Cross-sectional evaluation
3.3.1. Number of motor units
The mean thenar MUNE in the 22 ALS patients was
67.1 ± 90.6 motor units (range: 3–360). In comparison
with the mean thenar MUNE in volunteers (263.3 ±
116.8), Student’s t test indicated a highly significant differ-
ence (t = 11.1, P ! 0.001) (Table 2).
It can be seen from Table 1 and Fig. 1A that, among
the 22 patients with ALS, only 5 (patients 1, 5, 19, 21 and
22) had thenar MUNE within normal limits according to
age. When AMPS was applied, these 5 patients had no
clinical and electromyographic evidence of thenar muscle
involvement. All the other patients had MUNE less than the
lower normal limit. This was true even for patient 12 who,
on the basis of clinical and classical electrophysiological
examinations, did not seem to have thenar muscle involve-
ment.
3.3.2. Size of motor units
The mean average S-MUAP size in the 22 ALS patients
was 352.9 ± 328.4 mV⋅ms (range: 73–1250). The maximum
individual motor unit size was 3634 mV⋅ms. Thus, the mean
average S-MUAP size in ALS was 4 times normal (94.1
mV⋅ms) while some S-MUAPs were as much as 39 times
normal. This indicated that some motor unit sizes remained
within normal limits while others became extremely large.
Fig. 3, which represents the distribution of the individual
motor unit sizes in thenar muscles from each control subject
and ALS patient, confirms that, in ALS, it was not uncom-
mon for some motor unit potentials to increase much more
in size than others. Student’s t test revealed that the differ-
ence between the mean in ALS and that in normal subjects
(94.1 ± 30.3) was also highly significant (t = 9.8, P !
0.001) (Table 2).
Table 1 and Fig. 1B show that 6 patients (patients 1, 5, 7,
19, 21 and 22) had average S-MUAP size within normal
limits. MUNE in patients 1, 5, 19, 21 and 22 was also, as
mentioned above, within normal limits, while patient 7 had
a decreased MUNE. The 16 other patients had motor unit
sizes above the upper limit of normal. However, in patients
4, 11, 13 and 15 (ALS at a terminal clinical stage), average
S-MUAP size was increased only moderately.
3.3.3. Size of maximum M-potentials
The mean thenar maximum M-potential size in the 22
Fig. 2. Reproducibility of the adapted multiple point stimulation method
assessed by the coefficient of variation between data collected on two
successive trials (test 1 and test 2) from 10 amyotrophic lateral sclerosis
patients. (A) Motor unit number estimates from the two trials were sig-
nificantly correlated (r = 0.97, P ! 0.001) and the coefficient of variation
(CV) was 4%. (B) Average surface-recorded motor unit action potential
sizes from the two trials were also significantly correlated (r = 0.92,
P ! 0.001) and the CV was 4%.
Table 2
Comparison of AMPS results from normal subjects and ALS patients (means ± SD)
Variables Normal subjects (n) ALS patients (n) Student’s t test
Motor unit number estimate 263.3 ± 116.8 (70) 67.1 ± 90.6 (22) t = 11.1*
Average surface-recorded motor unit
action potential size (mV⋅ ms)
94.1 ± 30.3 (70) 352.9 ± 328.4 (22) t = 9.8*
Maximum M-potential size (mV⋅ms) 21.9 ± 7.7 (70) 11.4 ± 8.9 (22) t = 5.4*
*P ! 0.001.
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ALS patients was 11.4 ± 8.9 mV⋅ms (range: 0.7–31.3).
When compared with the mean thenar maximum M-poten-
tial in volunteers (21.9 ± 7.7), there was a significant dif-
ference (t = 5.4, P ! 0.001) (Table 2).
As shown in Table 1 and Fig. 1C, 13 ALS patients had
maximum M-potential sizes within normal limits. Nine
patients, in particular those with ALS in a terminal clinical
stage (patients 4, 11, 13 and 15), had maximum M-potential
sizes less than the lower normal limit.
3.3.4. Relationship between MUNE and average S-MUAP
size
Fig. 4 shows that there was a statistically significant rela-
tionship between MUNE and average S-MUAP size
(r = −0.60, P ! 0.01, lnY = 9.97–1.17 lnX). Thus, low
MUNEs were associated with high average S-MUAP sizes
and vice versa. Fig. 4 also indicates that the 4 patients with
ALS in a terminal clinical stage (patients 4, 11, 13 and 15)
did not behave like other patients. Indeed, in these patients,
the average S-MUAP size was lower than the size expected
from the thenar MUNE. The disease duration, from the time
of first reported symptoms, in these patients was 48, 36, 96
and 84 months respectively.
3.4. Longitudinal evaluation
Fig. 5 shows AMPS results obtained from 8 ALS patients
(patients 14, 15, 16, 17, 18, 20, 21 and 22) who were studied
Fig. 3. Distribution of the individual surface-recorded motor unit action
potential sizes: (A) in 70 control subjects; and (B) in 22 amyotrophic
lateral sclerosis patients. The two SD limits outside the mean value give
the lower and upper normal limits.
Fig. 4. Relationship between motor unit number estimate (MUNE) and
average surface-recorded motor unit action potential (S-MUAP) size in
amyotrophic lateral sclerosis (ALS) patients (circles = patients with ALS
at a terminal clinical stage).
Fig. 5. Adapted multiple point stimulation results obtained from 8 amyo-
trophic lateral sclerosis patients before and after 2 and 6 months of a
glutamate-release antagonist (riluzole) treatment. (A) Mean motor unit
number estimates (MUNEs). (B) Mean average surface-recorded motor
unit action potential (S-MUAP) sizes (standard errors of the mean indi-
cated by bars).
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repetitively before and after 2 and 6 months of riluzole
therapy.
3.4.1. Number of motor units
At the start, mean thenar MUNE was 49.4 ± 60.5
motor units; after 2 months of treatment, mean MUNE
was 34.1 ± 46.6 motor units. Paired Student’s t test indi-
cated a significant difference between these two means
(t = 4.2, P ! 0.01) (Fig. 5A). The mean thenar MUNE
after 6 months of treatment was 23.3 ± 32.6 motor units.
In comparison with the mean thenar MUNE after 2 months
of treatment, paired Student’s t test also indicated a sig-
nificant difference (t = 3.6, P ! 0.01) (Fig. 5A). The
mean loss of motor units over 6 months of treatment reached
53%.
3.4.2. Size of motor units
Before treatment, mean average S-MUAP size was
354.1 ± 260.9 mV⋅ms. After 2 and 6 months of rilu-
zole therapy, this mean value reached 439.4 ± 322.6
mV.ms and 682.5 ± 700.6 mV⋅ms respectively. Paired Stu-
dent’s t test indicated no significant difference between the
different means (Fig. 5B). However, it can be seen from
Table 1 that 5 ALS patients (patients 17, 18, 20, 21 and
22) presented a progressive average S-MUAP size
increase after 2 and 6 months of treatment; while an
average S-MUAP size decrease was observed in two
patients (patients 14 and 15) after 2 months of treat-
ment and in one patient (patient 16) after 6 months of treat-
ment.
4. Discussion
As indicated in the results, AMPS in ALS patients is
manageable and easier to do than expected even if the
denervation is severe. Moreover, when thenar motor unit
number and average S-MUAP size are estimated on two
successive trials in the same patients, the results are repro-
ducible (Fig. 2).
4.1. Cross-sectional study
Several motor unit counting methods have shown pro-
gressive loss of functioning motor units with advance of
ALS (McComas et al., 1971a,b; McComas et al., 1973;
Brown and Jaatoul, 1974; Sica et al., 1974; Hansen and
Ballantyne, 1978; Daube, 1988; Strong et al., 1988; Dantes
and McComas, 1991; Bromberg, 1993). From this point of
view, AMPS is particularly appropriate to approach quanti-
tatively the motor unit loss which characterizes ALS.
Indeed, only 5 patients (patients 1, 5, 19, 21 and 22) have
their motor unit numbers within normal limits at the
moment of examination (Table 1 and Fig. 1A). Moreover,
when AMPS is applied, these 5 patients have no sign of
motor denervation in hand muscles and a diagnosis of
ALS is made on the basis of clinical and electrophysiologi-
cal signs in other parts of the body. In patient 12, there is no
evidence of thenar muscle involvement either but MUNE is
less than the lower normal limit. Thus, decreased MUNE is
probably one of the most sensitive signs of motor denerva-
tion. From this point of view, it would be useful to make
comparisons between the thenar strength as measured clini-
cally, the findings on needle electromyography and the para-
meters derived by AMPS. However, Bromberg et al. (1993)
have already shown, by making comparisons between
MUNE values, isometric strength, compound muscle action
potential (CMAP) amplitude, S-MUAP amplitude, fiber
density, macro-EMG potential amplitude, turns-to-ampli-
tude ratio, amplitude and recruitment pattern of low thresh-
old voluntary motor units in ALS, that MUNE measure-
ments are best suited to provide insight into the true natural
history of the disease process and may be clinically useful to
follow progression and response in drug trials. More
recently, by comparing MUNEs, mean thenar S-MUAPs
and CMAPs, isometric hand grip strength, total Medical
Research Council manual muscle testing score, Appel
ALS rating scale and force vital capacity, Felice (1997)
concluded that MUNE values were the most sensitive
index for documenting changes in disease progression
over time.
By using different electrophysiological techniques,
various authors demonstrated that mean motor unit po-
tential area increased in ALS to 2–4 times normal and
the maximum motor unit size until 57 times normal (McCo-
mas, 1977; Hansen and Ballantyne, 1978; Sta˚lberg and San-
ders, 1984; Strong et al., 1988). Our data on S-MUAP size
confirm on average that in ALS, the motor unit size
increased progressively with loss of motor units (Table 1,
Figs. 1B and 4). However, the motor unit size increase is not
uniform. Some motor units remain within normal size limits
but others become extremely large (Fig. 3). This is not
surprising since ALS must be considered a dynamic patho-
logical process, lasting generally for a few years, during
which death of one motorneuron leads to collateral reinner-
vation restricted to the remaining motor units in its close
vicinity.
The relationship between MUNE and the average S-
MUAP size (Fig. 4) indicates that in the 4 patients with
ALS in a terminal clinical stage (patients 4, 11, 13 and
15), the motor unit size increase is less important than in
other patients. This fact might result from a methodological
bias consisting of taking into account the small responses
which might be evoked from distant motor units such as the
lumbrical muscles. However, motor responses from distant
units were characterized by an initial positive phase and
were rejected from the analysis. Thus, two hypotheses
must be considered to explain low average S-MUAP sizes
estimated in these 4 patients. Either these patients suffer
from a particularly acute form of ALS and collateral rein-
nervation is less efficacious in compensating for motor
denervation, or there is a secondary motor unit size
41F.C. Wang, P.J. Delwaide / Electroencephalography and clinical Neurophysiology 109 (1998) 36–43
decrease. The disease duration, from the time of first
reported symptoms, in these patients (48, 36, 96, 84 months,
respectively) does not argue in favor of an acute form of
ALS. In a recent longitudinal study in ALS patients,
Emeryk-Szajewska et al. (1997) have well documented
the biphasic MUAP amplitude and area evolution. They
confirmed that reinnervation was able to compensate for
the loss of over 50% of motor units; but only transitorily.
Indeed in later stages, single MUAP parameters such as
amplitude and area decreased and sometimes fell close to
normal values. This result leads to the following comment:
if the average S-MUAP size in a patient with ALS is within
normal limits, either the studied muscle is healthy, or the
disease is severely decompensated without effective collat-
eral reinnervation.
Values of maximum M-potential confirm that collateral
reinnervation is able, from an electrophysiological point
of view, to compensate for motor denervation. Indeed, 13
patients kept their maximum M-potential size within
normal limits (Fig. 1C). However, in the terminal clin-
ical stage of ALS, motor denervation is no longer com-
pensated. In this case, the maximum M-potential size
falls below the lower normal limit. Thus, maximum
M-potential size might be considered as an electro-
physiological clue about ALS compensation or decompen-
sation.
4.2. Longitudinal study
In the 8 ALS patients under riluzole therapy, a dramatic
accelerated loss of motor units (53% after 6 months of treat-
ment) is measured (Fig. 5A), which contrasts with the phy-
siological loss of motor units (1.3% per year) (Wang and
Delwaide, 1995a). As there was no comparison possible
with patients not under riluzole - a protocol more and
more difficult from an ethical point of view - no conclusion
can be drawn concerning efficacy of this treatment; however
such a double blind study would be welcome.
The mean motor unit size does not significantly increase
(using paired Student’s t test) after 6 months of treatment.
However, in 5 patients (patients 17, 18, 20, 21 and 22)
average S-MUAP size progressively increases after 2 and
6 months of treatment while in 3 patients average S-MUAP
size decreases either after 2 (patients 14 and 15) or 6 (patient
16) months of treatment (Table 1). These surprising sequen-
tial S-MUAP size changes might be related to technical
changes due, for instance, to variation in recording electrode
placement. However, the reproducibility of AMPS results
evaluated by a test/retest reliability (Fig. 2) implied the
removal and replacement of surface recording electrodes
for the second trial. Thus, the average S-MUAP size
decrease observed in these 3 patients might rather reflect
again the dynamic aspect of ALS and might indicate ‘dis-
integration’ of motor units reinnervated at earlier stages
(Emeryk-Szajewska et al., 1997) or the loss of some parti-
cularly large motor units.
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